Dr. Maria Doreen Alne, MD

Dr. Alne practices at RWJBH Primary Care Services in Old Bridge, New Jersey.

Dr. Alne's NPI, 1275980336, was assigned on May 18, 2016. Dr. Alne holds New Jersey license 25MA10520300.

Dr. Alne's primary practice is RWJBH Primary Care Services, at 2101 County Route 516, Old Bridge, NJ 08857 in Middlesex County. The practice phone is (732) 867-9618.

Dr. Alne's primary practice is RWJBH Primary Care Services in Old Bridge, New Jersey. Dr. Alne is also affiliated with Jersey Shore University Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Alne to 4 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alne practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alne's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Alne is licensed in New Jersey.

CMS data shows 1,501 Medicare services from Dr. Alne across 9 procedure codes in 2024, for 440 Medicare patients. Medicare paid $77,408 for them. Every service was in an office.

CMS counts 440 Medicare patients who saw Dr. Alne in 2024. The largest group is 65 to 74, with 210 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alne's median patient age at 67, with 61% women.

In 2024, Dr. Alne wrote 7,208 Medicare Part D claims for 640 patients. 83% of them were for generic drugs. CMS names the drug for 6,408 of them, across 123 drugs with 11 or more claims each, at $771,608 in total drug cost. In 2023, CMS named 5,173 claims across 113 drugs.

Dr. Alne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alne as offering telehealth.

CMS Open Payments shows 691 general payments to Dr. Alne from 40 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $2,496.